Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ajay Duseja

Showing results (321-330 of 387) with videos related to

Pageof 39
Sort By:
Journal of Gastroenterology and Hepatology|July 4, 2017
Asia-Pacific Working Party on Non-alcoholic Fatty Liver Disease guidelines 2017-Part 1: Definition, risk factors and assessmentVincent Wai-Sun Wong, Wah-Kheong Chan, Shiv Chitturi, et al.
Journal of Clinical and Experimental Hepatology|October 13, 2017
Corrigendum to "Indian National Association for Study of the Liver (INASL) guidance for antiviral therapy against HCV infection: Update 2016" [J. Clin. Exp. Hepatol. 6 (2016) 119-145]Pankaj Puri, Vivek A Saraswat, Radha K Dhiman, et al.
Journal of Clinical and Experimental Hepatology|December 3, 2015
Indian National Association for Study of the Liver (INASL) Guidance for Antiviral Therapy Against HCV Infection in 2015Pankaj Puri, Anil C Anand, Vivek A Saraswat, et al.
Journal of Gastroenterology and Hepatology|July 11, 2017
The Asia-Pacific Working Party on Non-alcoholic Fatty Liver Disease guidelines 2017-Part 2: Management and special groupsShiv Chitturi, Vincent Wai-Sun Wong, Wah-Kheong Chan, et al.
Journal of Clinical and Experimental Hepatology|August 6, 2016
Indian National Association for Study of the Liver (INASL) Guidance for Antiviral Therapy Against HCV Infection: Update 2016Pankaj Puri, Vivek A Saraswat, Radha K Dhiman, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|November 27, 2018
Effects of Alcohol Consumption and Metabolic Syndrome on Mortality in Patients With Nonalcoholic and Alcohol-Related Fatty Liver DiseaseZobair M Younossi, Maria Stepanova, Janus Ong, et al.
Metabolic Syndrome and Related Disorders|January 27, 2022
Clinicopathological Profile and Outcome of a Large Cohort of Patients with Nonalcoholic Fatty Liver Disease from South Asia: Interim Results of the Indian Consortium on Nonalcoholic Fatty Liver DiseaseAjay Duseja, Shivaram P Singh, Manu Mehta, et al.
Journal of Hepatology|August 27, 2023
Uniting to defeat steatotic liver disease: A global mission to promote healthy livers and healthy livesAleksander Krag, Maria Buti, Jeffrey V Lazarus, et al.
Journal of Clinical and Experimental Hepatology|May 9, 2025
Indian National Association for the Study of Liver (INASL) Guidance Statements for Determining Futility in Liver TransplantationAnil Arora, Praveen Sharma, Ashish Kumar, et al.
Communications Medicine|July 29, 2025
Survey on the perceptions of Asian endoscopists to artificial intelligenceSabrina Xin Zi Quek, Chieh Sian Koo, Lin Liu, et al.
Pageof 39

Showing results (321-330 of 387) with videos related to

Sort By:
Pageof 39
Journal of Gastroenterology and Hepatology|July 4, 2017
Asia-Pacific Working Party on Non-alcoholic Fatty Liver Disease guidelines 2017-Part 1: Definition, risk factors and assessmentVincent Wai-Sun Wong, Wah-Kheong Chan, Shiv Chitturi, et al.
Journal of Clinical and Experimental Hepatology|October 13, 2017
Corrigendum to "Indian National Association for Study of the Liver (INASL) guidance for antiviral therapy against HCV infection: Update 2016" [J. Clin. Exp. Hepatol. 6 (2016) 119-145]Pankaj Puri, Vivek A Saraswat, Radha K Dhiman, et al.
Journal of Clinical and Experimental Hepatology|December 3, 2015
Indian National Association for Study of the Liver (INASL) Guidance for Antiviral Therapy Against HCV Infection in 2015Pankaj Puri, Anil C Anand, Vivek A Saraswat, et al.
Journal of Gastroenterology and Hepatology|July 11, 2017
The Asia-Pacific Working Party on Non-alcoholic Fatty Liver Disease guidelines 2017-Part 2: Management and special groupsShiv Chitturi, Vincent Wai-Sun Wong, Wah-Kheong Chan, et al.
Journal of Clinical and Experimental Hepatology|August 6, 2016
Indian National Association for Study of the Liver (INASL) Guidance for Antiviral Therapy Against HCV Infection: Update 2016Pankaj Puri, Vivek A Saraswat, Radha K Dhiman, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|November 27, 2018
Effects of Alcohol Consumption and Metabolic Syndrome on Mortality in Patients With Nonalcoholic and Alcohol-Related Fatty Liver DiseaseZobair M Younossi, Maria Stepanova, Janus Ong, et al.
Metabolic Syndrome and Related Disorders|January 27, 2022
Clinicopathological Profile and Outcome of a Large Cohort of Patients with Nonalcoholic Fatty Liver Disease from South Asia: Interim Results of the Indian Consortium on Nonalcoholic Fatty Liver DiseaseAjay Duseja, Shivaram P Singh, Manu Mehta, et al.
Journal of Hepatology|August 27, 2023
Uniting to defeat steatotic liver disease: A global mission to promote healthy livers and healthy livesAleksander Krag, Maria Buti, Jeffrey V Lazarus, et al.
Journal of Clinical and Experimental Hepatology|May 9, 2025
Indian National Association for the Study of Liver (INASL) Guidance Statements for Determining Futility in Liver TransplantationAnil Arora, Praveen Sharma, Ashish Kumar, et al.
Communications Medicine|July 29, 2025
Survey on the perceptions of Asian endoscopists to artificial intelligenceSabrina Xin Zi Quek, Chieh Sian Koo, Lin Liu, et al.
Pageof 39